Erste Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Erste Asset Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.11M	Hold	38,520	–	–	0.02%	359
2025 Q4	$2.31M	Hold	38,520	–	–	0.02%	339
2025 Q3	$2.08M	Sell	38,520 -10,276	-21%	-$588K	0.02%	344
2025 Q2	$2.69M	Sell	48,796 -1,892	-4%	-$111K	0.02%	359
2025 Q1	$3.52M	Sell	50,688 -19,247	-28%	-$1.29M	0.05%	253
2024 Q4	$4.58M	Sell	69,935 -620,000	-90%	-$41.5M	0.06%	245
2024 Q3	$48.5M	Sell	689,935 -4,190	-0.6%	-$350K	0.58%	46
2024 Q2	$57.3M	Buy	694,125 +80,000	+13%	+$6.66M	0.76%	35
2024 Q1	$53.8M	Sell	614,125 -20,000	-3%	-$1.79M	0.73%	39
2023 Q4	$61.2M	Buy	634,125 +26,000	+4%	+$2.3M	0.9%	23
2023 Q3	$53.9M	Buy	608,125 +18,533	+3%	+$1.65M	0.93%	18
2023 Q2	$51.3M	Buy	589,592 +348	+0.1%	+$32.7K	0.9%	21
2023 Q1	$57.1M	Buy	589,244 +75,030	+15%	+$7.78M	1.09%	13
2022 Q4	$53.1M	Sell	514,214 -1,020	-0.2%	-$95.8K	1.12%	13
2022 Q3	$43.7M	Buy	515,234 +3,964	+0.8%	+$353K	0.98%	18
2022 Q2	$42.5M	Sell	511,270 -50,380	-9%	-$4.01M	0.94%	19
2022 Q1	$43.4M	Sell	561,650 -46,650	-8%	-$3.9M	0.83%	30
2021 Q4	$54.2M	Hold	608,300	–	–	0.98%	16
2021 Q3	$47M	Buy	608,300 +3,400	+0.6%	+$268K	0.93%	21
2021 Q2	$50.5M	Hold	604,900	–	–	1.01%	18
2021 Q1	$45.6M	Buy	604,900 +71,360	+13%	+$5.83M	1.12%	18
2020 Q4	$46.3M	Buy	533,540 +70,800	+15%	+$5.61M	1.28%	11
2020 Q3	$35.2M	Buy	462,740 +84,900	+22%	+$8.59M	1.2%	12
2020 Q2	$46.5M	Buy	377,840 +49,640	+15%	+$4.93M	1.85%	5
2020 Q1	$27.5M	Sell	328,200 -111,700	-25%	-$9.62M	1.6%	8
2019 Q4	$37.3M	Buy	439,900 +32,100	+8%	+$2.42M	1.65%	6
2019 Q3	$27.6M	Buy	407,800 +1,520	+0.4%	+$117K	1.47%	14
2019 Q2	$34.6M	Buy	406,280 +54,300	+15%	+$4.65M	1.84%	6
2019 Q1	$31.2M	Buy	351,980 +140	+0%	+$13K	1.75%	9
2018 Q4	$29.4M	Buy	+351,840	New	+$33.5M	1.98%	8